Characterizing nicotine withdrawal in pregnant cigarette smokers

被引:17
|
作者
Heil, Sarah H.
Higgins, Stephen T.
Mongeon, Joan A.
Badger, Gary J.
Bernstein, Ira M.
机构
[1] Univ Vermont, Dept Psychiat, Burlington, VT 05405 USA
[2] Univ Vermont, Dept Psychol, Burlington, VT 05405 USA
[3] Univ Vermont, Dept Med Biostat, Burlington, VT 05405 USA
[4] Univ Vermont, Dept Obstet & Gynecol, Burlington, VT 05405 USA
关键词
smoking abstinence; pregnancy; nicotine withdrawal;
D O I
10.1037/1064-1297.14.2.165
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Maternal smoking is a leading preventable cause of poor pregnancy outcomes and infant morbidity and mortality. Whereas pregnancy has been thought of as a "window of opportunity" when women are more motivated to change health behaviors such as smoking, only 20% of pregnant women quit smoking upon learning they are pregnant and remain abstinent at the end of the pregnancy. Greater understanding of possible obstacles to smoking during pregnancy, such as nicotine withdrawal, is needed. The symptoms of nicotine withdrawal have been well characterized in nonpregnant smokers, but there has been only I report conducted during pregnancy, and that was a retrospective study. The aim of the present study was to characterize nicotine withdrawal and craving in pregnant cigarette smokers. These data were collected as part of prospective clinical trials assessing the efficacy of voucher-based incentives to promote abstinence from cigarette smoking during pregnancy and postpartum. The authors examined results from the Minnesota Nicotine Withdrawal Scale (J. R. Hughes & D. K. Hatsukami, 1998) in 27 abstainers (reported no or very low levels of smoking, which was confirmed biochemically) and 21 smokers (smoked at > 80% of their baseline smoking level) during the first 5 days of a cessation attempt. Abstainers reported more impatience, anger, and difficulty concentrating than did smokers. The results also suggest that pregnant smokers generally may have elevated baseline levels of withdrawal, which need to be considered in the design and analysis of future studies.
引用
下载
收藏
页码:165 / 170
页数:6
相关论文
共 50 条
  • [21] NICOTINE ELIMINATION AND TOLERANCE IN NONDEPENDENT CIGARETTE SMOKERS
    SHIFFMAN, S
    ZETTLERSEGAL, M
    KASSEL, J
    PATY, J
    BENOWITZ, NL
    OBRIEN, G
    PSYCHOPHARMACOLOGY, 1992, 109 (04) : 449 - 456
  • [22] PUFFING FREQUENCY AND NICOTINE INTAKE IN CIGARETTE SMOKERS
    ASHTON, H
    WATSON, DW
    BRITISH MEDICAL JOURNAL, 1970, 3 (5724): : 679 - &
  • [23] Naltrexone blockade of nicotine effects in cigarette smokers
    Brauer, LH
    Behm, FM
    Westman, EC
    Patel, P
    Rose, JE
    PSYCHOPHARMACOLOGY, 1999, 143 (04) : 339 - 346
  • [24] EFFECTS OF SUPPLEMENTARY NICOTINE IN REGULAR CIGARETTE SMOKERS
    TURNER, JAM
    SILLETT, RW
    TAYLOR, DM
    MCNICOL, MW
    POSTGRADUATE MEDICAL JOURNAL, 1977, 53 (625) : 683 - 686
  • [25] Mecamylamine does not precipitate withdrawal in cigarette smokers
    Eissenberg, T
    Griffiths, RR
    Stitzer, ML
    PSYCHOPHARMACOLOGY, 1996, 127 (04) : 328 - 336
  • [26] Mecamylamine does not precipitate withdrawal in cigarette smokers
    Eissenberg, T
    Griffiths, RR
    Liebson, IA
    Lichtman, D
    Stitzer, ML
    ADDICTION, 1997, 92 (05) : 624 - 624
  • [27] The effects of nicotine, denicotinized tobacco, and nicotine-containing tobacco on cigarette craving, withdrawal, and self-administration in male and female smokers
    Barrett, Sean P.
    BEHAVIOURAL PHARMACOLOGY, 2010, 21 (02): : 144 - 152
  • [28] EFFECT OF NICOTINE REPLACEMENT ON THE CIGARETTE WITHDRAWAL SYNDROME
    WEST, RJ
    JARVIS, MJ
    RUSSELL, MAH
    CARRUTHERS, ME
    FEYERABEND, C
    BRITISH JOURNAL OF ADDICTION, 1984, 79 (02): : 215 - 219
  • [29] EFFECT OF NICOTINE CHEWING GUM ON PLASMA NICOTINE LEVELS OF CIGARETTE SMOKERS
    EBERT, RV
    MCNABB, ME
    SNOW, SL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (04) : 495 - 498
  • [30] BEHAVIORAL REGULATION OF NICOTINE INTAKE IN CIGARETTE SMOKERS PRESENTED WITH A SHORTENED CIGARETTE
    STEPNEY, R
    THOMPSON, JW
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 (05) : 653 - 653